Get the latest Science News and Discoveries

Addition of immunotherapy continues to show survival benefit in prolonged follow-up in NRG Oncology trial for primary advanced stage or recurrent endometrial cancer - EurekAlert!

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Related news:

Addition of phosphonate groups boosts performance of organic electrochemical transistors - EurekAlert!

In addition to space stations, Vast says it will now build high-power satellites | “Every single successful space company is diversified in its products.”

Why Black women are at greater risk for fibroids and endometrial cancer

« JMIR Analysis: Consumer Wearables Emerge as the New Health Care Gatekeepers - EurekAlert!

Mysterious Stone in US Backyard Turns Out to Be an Archaeological Treasure »